Literature DB >> 11711032

Activity of diadenosine polyphosphates at P2Y receptors stably expressed in 1321N1 cells.

K Patel1, A Barnes, J Camacho, C Paterson, R Boughtflower, D Cousens, F Marshall.   

Abstract

The selectivities of the diadenosine polyphosphates (Ap(n)As, n=2-6) at the human P2Y(1), P2Y(2), P2Y(4), P2Y(6) and P2Y(11) receptors stably expressed in 1321N1 human astrocytoma cells was determined using a Fluorescence Imaging Plate Reader (FLIPR) to measure intracellular Ca(2+) mobilisation. The rank order of agonist potencies at P2Y(1) were: ADP>P(1),P(3)-diadenosine triphosphate (Ap(3)A)>P(1),P(3)-diadenosine hexaphosphate (Ap(6)A)=P(1),P(3)-diadenosine diphosphate (Ap(2)A)>>P(1),P(3)-diadenosine pentaphosphate (Ap(5)A). P(1),P(3)-diadenosine tetraphosphate (Ap(4)A) was inactive up to 1 mM. The rank order of agonist potencies at P2Y(2) were: UTP>Ap(4)A>>Ap(6)A>Ap(5)A>Ap(3)A>>Ap(2)A. The Ap(4)A concentration response curve appeared to be bi-phasic. At P2Y(4) all the Ap(n)As tested were inactive as agonists. At P2Y(6), only Ap(3)A and Ap(5)A showed significant agonist activity. At P2Y(11), only Ap(4)A showed significant agonist activity. Ap(n)As were inactive as antagonists of the P2Y(1), P2Y(2), P2Y(4), P2Y(6) and P2Y(11) receptors. At P2Y(4), however, the Ap(n)As potentiated the UTP response.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11711032     DOI: 10.1016/s0014-2999(01)01401-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

Review 1.  Nucleotides Acting at P2Y Receptors: Connecting Structure and Function.

Authors:  Kenneth A Jacobson; Silvia Paoletta; Vsevolod Katritch; Beili Wu; Zhan-Guo Gao; Qiang Zhao; Raymond C Stevens; Evgeny Kiselev
Journal:  Mol Pharmacol       Date:  2015-04-02       Impact factor: 4.436

2.  Purinergic receptors activating rapid intracellular Ca increases in microglia.

Authors:  Alan R Light; Ying Wu; Ronald W Hughen; Peter B Guthrie
Journal:  Neuron Glia Biol       Date:  2006-05

3.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

4.  Pharmacochemistry of the platelet purinergic receptors.

Authors:  Kenneth A Jacobson; Francesca Deflorian; Shilpi Mishra; Stefano Costanzi
Journal:  Purinergic Signal       Date:  2011-02-18       Impact factor: 3.765

5.  Diadenosine tetraphosphate as a potential therapeutic nucleotide to treat glaucoma.

Authors:  Begoña Fonseca; Alejandro Martínez-Águila; María J Pérez de Lara; Jesús Pintor
Journal:  Purinergic Signal       Date:  2016-11-16       Impact factor: 3.765

Review 6.  Allosteric modulation of purine and pyrimidine receptors.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao; Anikó Göblyös; Adriaan P Ijzerman
Journal:  Adv Pharmacol       Date:  2011

7.  Agonist and antagonist effects of diadenosine tetraphosphate, a platelet dense granule constituent, on platelet P2Y1, P2Y12 and P2X1 receptors.

Authors:  Hung Chang; Ivan B Yanachkov; Alan D Michelson; YouFu Li; M R Barnard; George E Wright; Andrew L Frelinger
Journal:  Thromb Res       Date:  2009-11-27       Impact factor: 3.944

8.  Identification of diadenosine triphosphate in Brugia malayi by reverse phase high performance liquid chromatography and MALDI mass spectrometry.

Authors:  Michael Kron; Joseph Leykam; Jessica Kopaczewski; Isaac Matus
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-06-23       Impact factor: 3.205

9.  Development of selective agonists and antagonists of P2Y receptors.

Authors:  Kenneth A Jacobson; Andrei A Ivanov; Sonia de Castro; T Kendall Harden; Hyojin Ko
Journal:  Purinergic Signal       Date:  2008-07-04       Impact factor: 3.765

10.  Signalling properties of inorganic polyphosphate in the mammalian brain.

Authors:  Kira M Holmström; Nephtali Marina; Artyom Y Baev; Nicholas W Wood; Alexander V Gourine; Andrey Y Abramov
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.